In what situations would you offer systemic therapy for HER2+ microinvasive invasive ductal carcinoma?
Community PollStarted
Which systemic therapy would you offer to patients with HER2+ microinvasive ductal carcinoma?
48 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · H Lee Moffitt Cancer Center, University of South Florida
Answered on · Updated on
I usually do not treat microinvasive HER2+ ductal cancer as most screen-detected cases still have a good prognosis and there is limited data for therapy benefit. A review by Padmore et al. (PMID 10717623) and a Chinese series (Si et al. Front Oncol 2020) suggested a higher risk of recurrence in youn...
Join for free or sign in to see the full answer